MedinCell S.A. (LON:0ACH)
16.03
-0.18 (-1.11%)
At close: Jul 16, 2025
MedinCell Revenue
In the fiscal year ending March 31, 2025, MedinCell had annual revenue of 27.73M EUR with 132.12% growth. MedinCell had revenue of 18.29M in the half year ending March 31, 2025, with 207.64% growth.
Revenue
27.73M EUR
Revenue Growth
+132.12%
P/S Ratio
20.07
Revenue / Employee
198.05K EUR
Employees
140
Market Cap
465.60M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 27.73M | 15.78M | 132.12% |
Mar 31, 2024 | 11.95M | -1.71M | -12.52% |
Mar 31, 2023 | 13.66M | 5.32M | 63.77% |
Mar 31, 2022 | 8.34M | 152.00K | 1.86% |
Mar 31, 2021 | 8.19M | 2.19M | 36.43% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |